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Abstract
Objective: To compare expert assessment with bibliometric indicators as tools to assess the quality and importance of
scientific research papers.
Methods and Materials: Shortly after their publication in 2005, the quality and importance of a cohort of nearly 700
Wellcome Trust (WT) associated research papers were assessed by expert reviewers; each paper was reviewed by two WT
expert reviewers. After 3 years, we compared this initial assessment with other measures of paper impact.
Results: Shortly after publication, 62 (9%) of the 687 research papers were determined to describe at least a ‘major addition
to knowledge’ –6 were thought to be ‘landmark’ papers. At an aggregate level, after 3 years, there was a strong positive
association between expert assessment and impact as measured by number of citations and F1000 rating. However, there
were some important exceptions indicating that bibliometric measures may not be sufficient in isolation as measures of
research quality and importance, and especially not for assessing single papers or small groups of research publications.
Conclusion: When attempting to assess the quality and importance of research papers, we found that sole reliance on
bibliometric indicators would have led us to miss papers containing important results as judged by expert review. In
particular, some papers that were highly rated by experts were not highly cited during the first three years after publication.
Tools that link expert peer reviews of research paper quality and importance to more quantitative indicators, such as
citation analysis would be valuable additions to the field of research assessment and evaluation.
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Introduction
The Wellcome Trust has spent over £2.5 bn on biomedical
research during the last 5 years in pursuit of its mission ‘to foster and
promote research with the aim of improving human and animal health.’A t
any one time, we support over 3000 researchers in more than 50
countries. One of the major challenges we face is the evaluation of
how and where our support is making a difference.
Like other organisations in the business of supporting research
to generate new knowledge, while we recognise the array of
outputs and impacts of research, the production of a scientific
research paper remains a good indication of research progression
and knowledge generation. There is a range of measures that can
be used to indicate the value of a research paper. There is also a
wide-ranging critique of bibliometric indicators [1,2,3]; knowing
who has published what and where, and understanding how this
work has been cited does not necessarily reflect the quality and
importance of the research being described, the potential impacts
or the longevity of a line of research. As Eugene Garfield wrote in
a recent review of the history and uses of Journal Impact Factors,
‘In an ideal world, evaluators would read each article and make personal
judgements’ [4]. It is this reasoning that has led to the development
of more qualitative tools of assessment of published outputs,
exemplified by the Faculty of 1000 (F1000) – an online service
where a selected group (‘Faculty’) of leading researchers and
clinicians highlight and evaluate what they consider to be the most
important articles emerging in biology and medicine (http://www.
facultyof1000.com/).
The emergence of more accessible electronic and web-based
bibliographic and reference tools has greatly improved access to
publication outputs. Since May 2005, the U.S. National Library of
Medicine (NLM) has been identifying and indexing biomedical
research papers, published in peer-reviewed journals and appear-
ing on PubMed, where the Wellcome Trust has been cited in the
acknowledgment section. From January 2008, this service has
extended to all UK PubMed Central (UKPMC) funders. This
presents unprecedented access to up-to-date, ‘live’ information on
the funding sources for scientific published outputs and the
opportunity to better understand the nature of those outputs.
We analysed the first 1000 research papers acknowledging
Wellcome Trust funding, indexed on the PubMed database
(published between May and September 2005) and tracked these
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project had three aims. The first was to characterise the spread of
publications and to assess the ‘quality’ of a large cohort of
Wellcome Trust associated publications, which prior to the
PubMed indexing of ‘Wellcome Trust’ had been difficult to do.
Our second aim was to compare the relative importance of
publication outputs associated with different funding mechanisms
– notably whether research funded through larger, longer-term
grants yielded higher quality output than smaller, short-term
grants - which is one of the most debated issues among research
funders. Our third aim was to explore the extent to which expert
predictions of ‘importance’ at the time of publication correlated
with impact and use according to more traditional bibliometric
measures. Comparison of expert review of scientific papers at the
time of publication with subsequent citation and other bibliometric
indicators provides useful insight into the validity of these
bibliometric measures as surrogates for the measurement of
research quality. This is relevant to the debate on the adoption of
more metrics-based approaches for research assessment – such as
is being proposed in the UK Research Excellence Framework
(REF) (successor to the Research Assessment Exercise (RAE)).
Materials and Methods
Accessing the cohort
Using the search criterion Wellcome Trust [gr] on PubMed,
details of the first consecutive 1000 papers associated with the
Wellcome Trust published between May and September 2005
were downloaded. The full text of these papers was accessed either
via the web, where the paper was available in an open or public
access journal or featured in a journal to which the Trust has a
subscription, or via request (and payment) from the British
Library.
The papers were manually scrutinized and those without a
biomedical research focus and/or incorrectly linked to the
Wellcome Trust - a small number of papers were linked to either
‘Burroughs-Wellcome’o r‘GlaxoWellcome’ - excluded from the analysis.
As a result the ‘PubMed 1000’ became 979, comprised of 157
review (16%) and 822 original research (84%) papers.
Characterising the papers
The journal title and publisher were noted for all 979 papers.
For original research papers (n=822) details of the author
number, institutional collaborations and additional/co-funders
were abstracted systematically and the journal impact factor of the
featuring journal at the time of publication derived.
A detailed analysis of the nature of the association to the
Wellcome Trust was conducted for each original research paper.
This was manual and labour intensive as more than two-fifths of
original research papers (n=327/822), other than acknowledging
the Wellcome Trust, did not provide any further information on
their association (e.g. grant number, author affiliation). Even
where there was some indication of the nature of the link to the
Wellcome Trust, much of the detail required for this project - such
as grant type – was not immediately obvious. As a result, and for
each paper, a combination of the information contained in the
acknowledgment section, author name/s and institutional ad-
dress/es and affiliation/s were cross-checked against the Wellcome
Trust’s grant database. In many cases, several Wellcome Trust
grants were associated with each paper. To simplify the analysis, a
maximum of four grants were linked to each paper - those deemed
most relevant to the research being chosen.
Papers were classified into broad scientific areas covering:
immunology and infectious diseases; molecular and cellular
biology; genetics; basic and cognitive neuroscience and mental
health; physiological sciences; and epidemiology and public health.
Wellcome Trust reviewers
An expert Review ‘College’ with relevant scientific expertise,
comprising 16 reviewers drawn from senior Trust scientific staff
and scientific leaders involved in the Trust’s funding committees,
was convened. Reviewers were paired and assigned papers
covering their broad scientific expertise. Each reviewer was
required to independently read their assigned papers and assess
the importance of each according to one of four, semantically-
differentiated, categories:
N ‘Landmark’ (assigned a score=4)
N ‘Major addition to knowledge’ (score=3)
N ‘Useful step forward’ (score=2)
N ‘For the record’ (score=1).
Reviewing was undertaken during December 2005; given that
the papers in the cohort were published between May and
September 2005, each paper had been published for a maximum
of 6 months at the time of its review. The journal in which each
paper appeared was not masked; reviewers were simply instructed
to assess the research paper itself. While there is evidence that
knowledge of author/s, institutional affiliation and featuring
journal can effect assessments of published outputs [5], in reality
such ‘biases’ are inherent throughout peer review and are difficult
to completely counter.
Two assessments were provided for 87% (n=716/822) of the
papers. For 106 papers, two assessments were not provided due to
either a conflict of interest for the reviewer and/or the paper being
outside the reviewer’s area of expertise. Where two reviews were
provided, assessments of importance matched exactly, or were one
category apart, on 96% of papers (n=687/716). Where
assessments were more than one category apart, the assessment
for that paper was ‘unresolved’ and excluded from this initial
analysis (n=29/716). Thus 687 papers received a ‘complete
review’ and were included in the subsequent analysis. A simple
scoring system was devised to reflect the importance rating of each
paper – the score assigned to each paper being the sum of the two
scores of the reviewers, ranging from ‘2’ (where both reviewers
assigned a score of 1 - ‘for the record’) to a maximum of 8 (where
both reviewers assigned a score of 4 - ‘landmark’ paper).
We calculated the weighted kappa statistic to indicate the level
of agreement on ‘importance’ between reviewers across all
reviewed papers. The weighted kappa statistic overall was 0.132
(‘slight’), indicating that reviewers were likely to agree in their
assignment of importance more than would have occurred by
chance.
Tracking & analysing the performance of the papers
After 3 years, ‘performance’ data on all papers was compiled by
using the Scopus (citations) and the F1000 (F1000 score and
assessment) databases.
As patterns of reviewers’ ratings and citations were not normally
distributed, non-parametric tests were used to derive levels of
statistical significance. Spearman’s Rank Correlation (rs) was used
to measure the level and the statistical significance of the
association between reviewers’ ratings and other measures of
paper performance. The Mann-Whitney U test was used to test
the statistical significance of the differences in citation volume of
papers associated with three major funding mechanisms (pro-
gramme and project grants and fellowships).
Expert Review & Bibliometrics
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The cohort of 979 papers (822 original research and 157 review
papers) appeared across 432 different journals, published by 98
different publishers. Original research papers (n=822) were not
concentrated in specific journals; the Journal of Biological
Chemistry, featured the highest number of papers (n=22) and
only 11 journals featured more than 10 papers. Seventy per cent of
original research papers (n=573/822) appeared in a journal with
a Journal Impact Factor (JIF) above 3.
A large proportion of the papers resulted from collaborative
work involving multiple research institutions, often in several
countries; less than half (47%) of original research papers were
generated solely from UK-based researchers. Nearly two-thirds
(64% n=524/822) of original research papers listed five or more
authors. The original research papers were linked to over 900
different Wellcome Trust grants – though more than one
Wellcome Trust grant was often acknowledged on papers,
alongside a range of other funders. Less than a quarter (23%
n=189/822) of original research papers were linked solely to
Wellcome Trust support.
At the time of publication, nine per cent (n=62/687) of original
research papers were considered to describe at least a ‘major
addition to knowledge’ (Figure 1); six were considered to be
‘landmark’ papers – five of which appeared in Science and one in
Nature, all with an international health focus. Papers were most
commonly thought to describe a ‘useful step forward’, with a third
receiving this rating (33% n=229/687). There was a strong
positive correlation (Spearman’s coefficient, rs=0.625, significant
at 0.01) between the ‘importance rating’ assigned by our experts
and the Journal Impact Factor of the featuring journal (Figure 2).
By the beginning of October 2008 the papers in our cohort had
been published for 3 years. Overall papers received an average of
19.48 citations and a median of 12; only 9 papers were not cited at
all. There was a positive correlation (rs=0.45, significant at 0.01)
between our reviewers’ assessments of the ‘importance’ of the
research papers (as reviewed in 2005) and the papers’ use in the
wider community as indicated by citation totals three years later
(Figure 3). By the beginning of October 2008, 48 (7%) of the 687
original research papers assessed by our reviewers also featured on
the two F1000 databases. Our expert review scores were positively
correlated (rs=0.445, significant at 0.01) with the assessments of
these same papers on F1000 (Figure 4).
Details of the papers in the cohort receiving the highest scores
by our expert reviewers (review score 8; n=6) and F1000
reviewers (9.8, n=1) and three other papers achieving among the
highest volume of citations after 3 years, are listed in Table 1. All
10 of these papers describe a ‘new finding’, though the nature of
that ‘finding’ varies from a new genome sequence to new
epidemiological data. The top 3 most highly cited papers were
genomics-based and had over 80 authors. There is a significant
positive correlation between the number of authors and the
number of citations a paper has received (Figure 5).
Figures 3 and 4 are annotated to show the position of these
papers in relation to the various measurement criteria. Despite the
significant positive correlations between assessments of importance
Figure 1. ‘PubMed 1000’ original research papers – ‘importance rating’.
doi:10.1371/journal.pone.0005910.g001
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that there are exceptions; papers that were highly rated by expert
reviewers were not always the most highly cited, and vice versa.
Additionally, what was highly rated by one set of expert reviewers
may not be so by another set; only three of the six ‘landmark’
papers identified by our expert reviewers are currently recom-
mended on the F1000 databases.
One of the core aims of the project was to explore the relative
importance and performance of publication outputs associated
with different funding mechanisms. In terms of peer assessments of
‘importance’ and citation volume in the three years since
publication, there are indications that papers associated with
larger awards and training awards (programmes and fellowships
(excluding PhD studentships)) performed ‘better’ than papers
associated with shorter-term, smaller value awards (Table 2);
there is a statistically significant difference in the volume of
citations emerging from papers linked to programmes and
fellowships compared with those linked to projects (programmes
compared with projects – Mann-Whitney p=0.04; fellowships
compared with projects – Mann-Whitney p=,0.001)), Table 2).
As this may be in part a reflection of the size and constituency of
the team working on certain grants - for example it is likely that
larger programme grants and fellowships involve many, often
senior, researchers - research papers associated with such grants
may be more likely to have a larger number of associated authors
and potentially achieve higher citations rates both through the
involvement of ‘senior’ scientists and by virtue of the self-citations
linked to the further research of all members of the team.
However, this analysis of grant type should be treated tentatively
as the analysis was based on a cohort of papers published over a
specific period and not the total complement of outputs arising
from a cohort of grants, nor did we explore in detail the nature of
other, non-Wellcome Trust funding acknowledged on each paper.
As a key strategic issue for research funders, more detailed analyses
on the quality and merit of outputs associated with different
funding mechanisms are required.
Discussion
In response to the project aims, overall the different quantitative
(journal impact factors and citations) and qualitative (expert review
and F1000) analyses provide a relatively consistent assessment of
our cohort of papers. In addition, expert reviewers were broadly
able to predict the most ‘important’ papers, subsequently identified
by another set of experts (F1000) and in terms of their usage in the
scientific community, as defined by citations.
Historically, and taken at an aggregate level, bibliometric
measures have been used as a proxy indicator of research quality,
and particularly in areas, such as the biosciences, where
publication output remains a key indicator of research progression.
Indeed, this provides much of the rationale for the move to replace
the UK’s Research Assessment Exercise (RAE) with a more
Figure 2. ‘PubMed 1000’ – ‘importance rating’ & Journal Impact Factor (2005).
doi:10.1371/journal.pone.0005910.g002
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doi:10.1371/journal.pone.0005910.g003
Figure 4. ‘PubMed 1000’ – ‘importance rating’ (2005) & F1000 rating (2008).
doi:10.1371/journal.pone.0005910.g004
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science and research, and specifically within the biosciences, make
the interpretation of bibliometric analysis increasingly complex.
Scientific research is increasingly a collaborative, multi-
disciplinary, multi-location and multi-funded activity [8,9];
upward trends in paper author number are, at least in part, a
reflection of this. While this upward trend is also thought to be
linked to research assessment exercises such as the UK RAE
[10,11], it is also likely to continue where there is value in ‘big’,
collaborative, international science, such as in the area of
genomics. This in turn is likely to contribute to the higher author
numbers and citation rates typically found in genomics-based
papers but also across other areas. In addition, many scientific
papers describing a new technique or dataset with immediate
utility will be important immediately and highly cited; other
papers, often those describing a new insight to a specific field, will
be ‘slow burners’ taking time to gain acceptance and impact [12].
The distinct and different patterns of publication and citation
behaviour across areas of science are becoming better understood
as bibliometricians develop more insightful methods to accommo-
date and explain these [13]. The proliferation in the availability of
research findings in online, open and public access journals and
repositories is also changing the nature of access to research;
potentially impacting upon the usage and subsequent citation of
research. Add to this recent evidence that increasing access to
journals and information online may actually lead to a reduction in
the number of journals and citations as scientists more quickly tap
the consensus of opinion and build their research on this [14] and
we find ourselves in a situation where the interpretation of
bibliometric analysis as applied to science – and across different
fields within science – has become extremely complex.
In terms of more qualitative assessments of paper ‘importance’,
we found a good correlation between expert opinion and
subsequent ‘performance’ according to quantitative indicators.
However, as in traditional peer review and in existing studies
correlating expert assessments of the scientific value of a paper
with metrics [15], we found substantial variation in perceptions at
the level of individual papers. It can also be difficult to anticipate
the potential importance of a particular line of research at the time
of publication; for much basic, foundation-laying research it takes
time for its value to become evident [16,17]. An increasing
number of journals, particularly those based online, have
introduced features to enable reader ratings and encourage
critique and ‘blogs’ of published research papers. While these
can be useful, it can be hard to determine the ‘expertise’ of the
reviewer or commentator through these more informal mecha-
nisms of feedback.
We found a highly significant correlation between the
importance of papers identified by our expert panel and those
identified by the Faculty of 1000 experts. However, only 25 of the
62 papers characterised by our expert panel as being a ‘major
addition to knowledge’ or a ‘landmark’ paper were identified by
the Faculty of 1000. At least part of the explanation for this
discrepancy is that Faculty of 1000 makes no claims to be
systematic in its survey of the biomedical literature. Only
publications that form part of the regular scrutiny of the literature
Figure 5. ‘PubMed 1000’ – number of authors & citations (2008).
doi:10.1371/journal.pone.0005910.g005
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never assessed by Faculty of 1000 reviewers. These data do
support the concept that mechanisms such as Faculty of 1000 of
post-publication peer review are a valuable additional mechanism
for assessment of the quality of biomedical research literature.
Indeed, the data from the present study show that we may be able
to address some of the complexity in interpreting bibliometric data
combined with the inherent subjectivity of expert review by linking
qualitative assessments of paper impact and importance with more
quantitative assessments.
This work was enabled by our arrangement with the U.S.
National Library of Medicine, which systematically identified
research papers acknowledging Wellcome Trust funding. Howev-
er, inconsistencies in acknowledgment practice among authors and
journals meant that some papers containing work funded by the
Wellcome Trust would have been missed. It is also possible that
‘poorer’ quality papers may also be those providing less complete
acknowledgment information though there is no evidence to
suggest that this has introduced any systematic bias into this study.
Recent initiatives led by the NIH, the Wellcome Trust and
other UKPMC funders, to mandate researchers who receive their
funds to deposit papers in open access repositories, should also
help funders to gain greater understanding of and access to
research outputs associated with their funding support [18].
Furthermore, in recognition of the value of the acknowledgment
section of a research paper specifically, there have been several
Table 1. Highly cited & highly reviewed original research papers (October 2005 & 2008).







(Oct 08) Reason for F1000
1 Ivens AC et al. The genome of the kinetoplastid parasite, Leishmania
major. (2005) Science 309 (5733): 436–42
244 8 9 New finding
2 Berriman M et al. The genome of the African trypanosome Trypanosoma
brucei. (2005) Science 309 (5733): 416–22
239 8 9.6 New finding
3 El-Sayed NM et al. The genome sequence of Trypanosoma cruzi, etiologic
agent of Chagas disease. (2005) Science 309 (5733): 409–15
193 8 9 New finding
4 Hawley SA. et al. Calmodulin-dependent protein kinase kinase-beta is an
alternative upstream kinase for AMP-activated protein kinase. (2005) Cell
Metabolism 2 (1): 9–19
174 3 None N/A
5 Reilly JJ et al. Early life risk factors for obesity in childhood: cohort study.
(2005) BMJ 330 (7504): 1357–1359
174 5 None N/A
6 LaCava J et al. RNA degradation by the exosome is promoted by a nuclear
polyadenylation complex. (2005) Cell 121 (5): 713–24
155 7 None N/A
7 El-Sayed NM et al. Comparative genomics of trypanosomatid parasitic
protozoa.( 2 0 0 5 )Science 309 (5733): 404–9
111 8 None N/A
8 Carulla N et al. Molecular recycling within amyloid fibrils. (2005) Nature
436 (7050): 554–8
58 8 None N/A
9 Cliffe LJ et al. Accelerated intestinal epithelial cell turnover: A new
mechanism of parasite expulsion. (2005) Science 308 (5727): 1463–1465
45 7 9.8 New finding
10 Perez-Morga D et al. Apolipoprotein L-I promotes trypanosome lysis by
forming pores in lysosomal membranes. (2005) Science 309 (5733):
469–72
27 8 None N/A
Source: Wellcome Trust expert review (2005); F1000 & Scopus (2008).
Note: ‘key’ number represents annotation on Figures 3 & 4.
doi:10.1371/journal.pone.0005910.t001
Table 2. Original research papers (published 2005) linked to Programme, Fellowship and Project grants & citations per papers
(2008).
Grant type
Number of papers linked to





Programmes 181 0 244 23.07 13 5.5–23.5
Projects 279 0 244 14.66 9 5–18
Fellowships 214 0 239 22.16 14 7–26
Base: 558 original research papers linked to Programme, Fellowship (excluding PhD training studentships) and Project grants and assessed by Wellcome Trust
reviewers.
*many papers linked to more than one grant.
Source: Wellcome Trust, PubMed (2005) & Scopus (October 2008)
Note: Mann-Whitney tests show no statistically significant difference between the citation volume of papers linked to Programmes and Fellowships (Mann-Whitney
p=0.458), but significant differences between the citation volume of papers linked to Programmes, Fellowships and Projects: Programmes and Projects (Mann-Whitney
p=0.04); Fellowships and Projects (Mann-Whitney p=,0.001).
doi:10.1371/journal.pone.0005910.t002
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example, the acknowledgment section of papers featuring in
UKPMC are now fully searchable, and in January 2009, Thomson
Reuters introduced a facility to view and search acknowledgment
information on papers held in the Web of Science database. There
is also a body of research that has explored the options for
measuring scientific contributions through more automatic
acknowledgment indexing [19] and initiatives led by several
publishers and editors [20]. However, any ‘top down’ develop-
ments to improve access to information in the acknowledgment
section via bibliographic databases will be largely redundant if
researchers do not acknowledge their funding source systemati-
cally in the first place.
Led by the Research Information Network in the UK, working
with a number of research funders and publishers, a set of
simplified and standardised acknowledgment guidelines for
researchers has recently been introduced [21]. The guidelines
include a set of recommendations to publishers on how to code
information contained in an acknowledgment section and has also
recommended that publishers include a specific ‘funding’ section
on papers. Over time, the combination of ‘top down’ and ‘bottom
up’ approaches should improve access and add value to
information on published papers associated with research funding
and affiliation.
We were also interested to ask whether different types of
funding were associated with different qualities of output. We
stratified the cohort of publications funded by the Wellcome Trust
as project grants (typically three years funding for one or two posts
plus running costs), programme grants (typically five years funding
for four to six posts plus running costs) or fellowships (typically
salary support for the principal investigator for three to five years
associated with running costs and variable numbers of additional
posts). The outputs linked to project grants were cited significantly
less frequently than those linked to programme and fellowship
grants. This is a potentially important finding that we will dissect
further in future studies. In particular we intend to conduct more
detailed analyses of patterns of publication output, subsequent
citation and the lag time between funding and ‘impact’, in relation
to different grant types, the demographic characteristics of those
working on the grants, and the field of scientific research.
For all those that fund research, it is the products of the grant
funding that matter. Greater insight into the relative strengths of
different modes of funding research in enabling the production of
original and important published output would be a valuable input
to strategic decision-making for all those involved in supporting
research.
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